Find Clinical Trial

Efficacy and safety of bumetanide oral liquid formulation in children and adolescents aged from 7 to less than 18 years old with Autism Spectrum Disorder


← Back
Study Phase Phase 3
Therapeutic Area Neurosciences
Active Substance BUMETANIDES095008
SponsorInstitut de Recherches Internationales Servier (I.R.I.S)
Active Substance CodeS095008
Protocol CodeCL3-95008-001
EudraCT Code2017-004419-38
NCT CodeNCT03715166


Documents and links

Results are not yet available.




Servier Glossary of Terms

To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.



© 2017 LES LABORATOIRES SERVIER, an incorporated company of Servier.
All Rights Reserved. Servier does not sell its products over the Internet.
More information

Report a side-effect with a drug.